To assist in optimizing our clients' drug development objectives, we provide a full range of capabilities to support the conduct of Phase I-IIa clinical trials. Our scientific expertise and comprehensive service offerings help to achieve timely and cost-effective results, enabling our clients to experience a seamless transition from the preclinical to the clinical phase of drug development. In addition, our support systems, infrastructure, and established experience provide our clients with the highest level of program management and service in support of early-phase clinical trials. Our study directors are focused on providing individualized attention, offering flexibility in study designs and processes to meet our clients' specific research needs.
Southern Research capabilities include drug and drug metabolite method development, validation, and sample analysis in all human matrices. In addition, we offer custom immunological method development, validations, and sample analysis related to monitoring immune response to biological or protein therapies.
We provide comprehensive, early-phase clinical trial support services in the following key areas:
For more information about our capabilities, contact us at: